While these medications have marketing authorisations for specific indications, NHS access is governed by NICE technology appraisals, which set narrower eligibility criteria than the marketing authorisation
Overall, the use of metformin as an adjunct treatment for AN, particularly in patients with underlying hyperglycemia, is supported in the literature, but further studies are needed to clarify dosing, duration of therapy, and patient populations that will benefit most from adding metformin to their treatment regimens
Yes, peptides degrade over time
Benefits Enhances natural pulsatile growth hormone secretion: CJC-1295 (No DAC) amplifies endogenous growth hormone release by directly stimulating the GHRH receptor pathway in the anterior pituitary
We work closely with your existing healthcare providers and adjust programs based on your medical needs
Months 3 Through 6: Where the Biggest Changes Happen The stretch from week 12 to week 24 is consistently the fastest weight loss phase in Retatrutide clinical trials